XML 35 R22.htm IDEA: XBRL DOCUMENT v3.20.2

Accumulated other comprehensive income (loss)

9 Months Ended

Sep. 30, 2020

Accumulated other comprehensive income (loss)

NOTE 14 – Accumulated other comprehensive income (loss):

The components of, and changes within, accumulated other comprehensive income (loss) attributable to Teva are presented in the table below:

		Net Unrealized Gains (Losses)												Benefit Plans
		Foreign currency translation adjustments				Available-for-sale securities				Derivative financial instruments				Actuarial gains (losses) and prior service (costs) credits				Total
		(U.S. $ in millions)
Balance as of December 31, 2019		$	(1,794	)		$	—			$	(420	)		$	(98	)		$	(2,312	)
Other comprehensive income (loss) before reclassifications			(377	)			—				20				—				(357	)
Amounts reclassified to the statements of income			—				—				26				—				26
Net other comprehensive income (loss) before tax			(377	)			—				46				—				(331	)
Net other comprehensive income (loss) after tax*			(377	)			—				46				—				(331	)
Balance as of September 30, 2020		$	(2,171	)		$	—			$	(374	)		$	(98	)		$	(2,643	)

* Amounts do not include a $29 million gain from foreign currency translation adjustments attributable to non-controlling interests.

		Net Unrealized Gains (Losses)												Benefit Plans
		Foreign currency translation adjustments				Available-for-sale securities				Derivative financial instruments				Actuarial gains (losses) and prior service (costs) credits				Total
		(U.S. $ in millions)
Balance as of December 31, 2018		$	(1,878	)		$	1			$	(504	)		$	(78	)		$	(2,459	)
Other comprehensive income (loss) before reclassifications			(28	)			(1	)			103				*	*			74
Amounts reclassified to the statements of income			—				—				21				—				21
Net other comprehensive income (loss) before tax			(28	)			(1	)			124				*	*			95
Net other comprehensive income (loss) after tax*			(28	)			(1	)			124				(1	)			94
Balance as of September 30, 2019		$	(1,906	)		$	—			$	(380	)		$	(79	)		$	(2,365	)

* Amounts do not include a $23 million gain from foreign currency translation adjustments attributable to non-controlling interests.

** Represents an amount less than $0.5 million.

X

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

+ Details

Name:	us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration